Optimer Pharmaceuticals is subject to many possible offers from other drug companies. The antibiotics pharmaceutical maker Optimer Pharmaceuticals Inc has been the subject of interest from GlaxoSmithKline Plc and Astellas Pharma Inc of Japan.
Healthcare Health/Fitness
Two Major Health Supplement Firms Seek Investors
Santa Cruz Nutritionals and Nellson Nutraceutical LLG are seeking buyers. Three sources who spoke on condition of anonymity are confirming that Santa Cruz Nutritionals and Nellson Nutraceutical LLG are in the process of searching for buyers.
EveryMove Expands Capitalization and Technology Availability
Funding has been increased for EveryMove as well as availability of the app in Android's Play Store.
LCI Holdco Asset Sale Upheld
The bankruptcy court upheld the sale of assets of LCI Holdco LLC despite IRS opposition. The federal court with jurisdiction over the bankruptcy case of LCI Holdco LLC has approved the sale of the assets of the company to Hospital Acquisition LLC.
Royalty Pharma Urged for Firm Offer for Elan
Ireland’s Takeover Panel is urging United State's Royalty Pharma to firm offer for Irish drugmaker Elan by May 10.
Latest News
Hoping to maximize the wave of increased health care demand in Asia, Sanofi is building a new factory in Vietnam.
Pfizer acts on Celebrex and Bextra subject to shareholder class action suit. The world's biggest pharmaceutical firm now needs to face investor allegations that executives misled them about the athritis drugs Celebrex and Bextra.
In compliance with current regulations, Novartis AG is selling of a part of its shareholdings in Novartis India.
Shire pay US$160 million for SARcode Bioscience. Shire recently announced its purchase of privately owned US biotech firm SARcode Bioscience. The acquisition was worth US$160 million and central to the deal is the rights over a new drug in the late stages of development that helps cure dry eye disease.
Sanofi is seeking partnership for venture capital projects for its future portfolio. France's largest drugmaker Sanofi is seeking more deals with venture capitalists such as its agreement with biotechnology company Warp Drive Bio.
Warburg Pincus opens Bausch & Lomb for IPO at the same time seeking purchaser for the company. Bausch & Lomb Holdings Inc has recently filed papers with US regulators for its initial public offering.
Business software maker Model N share values jump by 44%. Share values of Model N increased by 44% at its trading debut with a market valuation reaching US$500 million.
Life Tech gains interest from buyout consortiums and pharmaceutical firms. Life Technologies Corp is up for sale and many important players in the industry are taking notice.
Cleary joins Tullis Health to help in its expansion plans. Michael Cleary was recently appointed by Tullis Health Investors as its new Director of Investor Relations and Marketing.
